Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Lansoprazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 86Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amarin Backs Advances in Elevated Triglyceride Therapy
    Amarin Backs Advances in Elevated Triglyceride Therapy

    09 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216008/18362/en/Amarin-Applauds-Breakthroughs-In-Therapies-For-Patients-With-Elevated-Triglycerides-Company-s-VASCEPA-VAZKEPA-Icosapent-Ethyl-Franchise-Well-Positioned-To-Benefit-Globally-From-Bro.html

    GLOBENEWSWIRE
    09 Jan 2026
    Share Share
    Amarin Announces Preliminary 2025 Financial Highlights
    Amarin Announces Preliminary 2025 Financial Highlights

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215221/18362/en/Amarin-Announces-Preliminary-2025-Financial-Highlights-and-Operational-Accomplishments-Including-Achieving-Positive-Cash-Flow-Company-Well-Positioned-to-Capture-Global-Growth-Oppor.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    New REDUCE-IT Analysis Reinforces Benefit Of Icosapent Ethyl
    New REDUCE-IT Analysis Reinforces Benefit Of Icosapent Ethyl

    09 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/09/3184162/18362/en/New-REDUCE-IT-Aspirin-Analysis-Presented-at-AHA-Scientific-Sessions-2025-Reinforces-VASCEPA-VAZKEPA-Icosapent-Ethyl-Reduced-Cardiovascular-Events-in-High-Risk-Patients.html

    GLOBENEWSWIRE
    09 Nov 2025
    Share Share
    Amarin To Showcase REDUCE-IT Data Strength at AHA 2025
    Amarin To Showcase REDUCE-IT Data Strength at AHA 2025

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179271/18362/en/Amarin-To-Present-New-Analyses-Affirming-Robustness-of-Data-from-REDUCE-IT-and-Additional-Mechanisms-of-Action-of-Eicosapentaenoic-Acid-EPA-at-American-Heart-Association-AHA-Scient.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Amarin Reports Third Quarter 2025 Financial Results
    Amarin Reports Third Quarter 2025 Financial Results

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176292/18362/en/Amarin-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Amarin Supports FDA Labeling Revision On Fenofibrate, Affirming
    Amarin Supports FDA Labeling Revision On Fenofibrate, Affirming

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174541/18362/en/Amarin-Issues-Statement-Supporting-FDA-s-Action-to-Revise-Labeling-for-Fenofibrate-Drugs-Reinforcing-a-Lack-of-Cardiovascular-Benefit.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.